Clinical trial
Enhancement of in-Vitro GC Function in Patients With COPD
NCT00241631 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00241631 |
|---|---|
| Title | Enhancement of in-Vitro GC Function in Patients With COPD |
| Official title | Enhancement of In-vitro GC Function in Patients With COPD. A Randomised, Double Blind, Placebo Controlled, Parallel-group Study to Investigate the Effect of Theophylline and Fluticasone on Induced Sputum Cells Obtained Form COPD Patients |
| Lead sponsor | Imperial College London, Other |
| Collaborators | Tanabe Pharma Corporation Industry Medical Research Council |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | COPD |
| Intervention type | Drug |
| Interventions | Fluticasone Propionate, placebo, Theophylline |
| Enrollment | 49 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Oct 19, 2005 |
| Last update posted | Dec 4, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: